Home
>
National Drug Code (NDC)
>
Xeloda
Xeloda - 0004-1100-20 - (capecitabine)
Drug Information of Xeloda
| Product NDC: | 0004-1100 |
| Proprietary Name: | Xeloda |
| Non Proprietary Name: | capecitabine |
| Active Ingredient(s): | 150 mg/1 & nbsp; capecitabine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Xeloda
| Product NDC: | 0004-1100 |
| Labeler Name: | Genentech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020896 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980430 |
Package Information of Xeloda
| Package NDC: | 0004-1100-20 |
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0004-1100-20) |
NDC Information of Xeloda
| NDC Code | 0004-1100-20 |
| Proprietary Name | Xeloda |
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0004-1100-20) |
| Product NDC | 0004-1100 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | capecitabine |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 19980430 |
| Marketing Category Name | NDA |
| Labeler Name | Genentech, Inc. |
| Substance Name | CAPECITABINE |
| Strength Number | 150 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
